Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Palmieri

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
Nature Reviews. Clinical Oncology|February 2, 2010
Surgical oncology: why biopsying metastatic breast cancer should be routineAnand Sharma, Tim Crook, Alastair Thompson, et al.
Expert Review of Anticancer Therapy|November 5, 2011
Role of fulvestrant in the management of postmenopausal breast cancerJonathan Krell, Adam Januszewski, Kelvin Yan, et al.
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|November 4, 2005
Targeted histone deacetylase inhibition for cancer prevention and therapyCarlo Palmieri, R Charles Coombes, David M Vigushin
Histopathology|September 3, 2009
An unusual triple-negative breast carcinomaSami Shousha, David Peston, Ondrej Gojis, et al.
Onkologie|January 16, 2009
The ethnic profile of triple-negative breast cancerSusan J Cleator, Carlo Palmieri, Charles R Coombes
BMJ (Clinical Research Ed.)|June 12, 2004
Hypocalcaemia after intravenous bisphosphonate: adjuvant bisphosphonate is not currently accepted practiceCarlo Palmieri, Tony Dhillon, Charles Coombes, et al.
The Lancet. Oncology|November 28, 2012
ChIPing away at breast cancerLuca Magnani, Jason Carroll, Wilbert Zwart, et al.
BMJ (Clinical Research Ed.)|January 1, 2009
Adjuvant radiotherapy for breast cancerCrispin Hiley, Andrew Tutt, Mylin Torres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Does ER-betacx really have no clinical importance in tamoxifen-treated breast cancer patients?Carlo Palmieri, Ondrej Gojis, Bharath Rudraraju, et al.
The Breast Journal|August 4, 2009
Fulvestrant in advanced breast cancer following tamoxifen and aromatase inhibition: a single center experienceJayson Wang, Sandeep Jain, Charles R Coombes, et al.
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
Nature Reviews. Clinical Oncology|February 2, 2010
Surgical oncology: why biopsying metastatic breast cancer should be routineAnand Sharma, Tim Crook, Alastair Thompson, et al.
Expert Review of Anticancer Therapy|November 5, 2011
Role of fulvestrant in the management of postmenopausal breast cancerJonathan Krell, Adam Januszewski, Kelvin Yan, et al.
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|November 4, 2005
Targeted histone deacetylase inhibition for cancer prevention and therapyCarlo Palmieri, R Charles Coombes, David M Vigushin
Histopathology|September 3, 2009
An unusual triple-negative breast carcinomaSami Shousha, David Peston, Ondrej Gojis, et al.
Onkologie|January 16, 2009
The ethnic profile of triple-negative breast cancerSusan J Cleator, Carlo Palmieri, Charles R Coombes
BMJ (Clinical Research Ed.)|June 12, 2004
Hypocalcaemia after intravenous bisphosphonate: adjuvant bisphosphonate is not currently accepted practiceCarlo Palmieri, Tony Dhillon, Charles Coombes, et al.
The Lancet. Oncology|November 28, 2012
ChIPing away at breast cancerLuca Magnani, Jason Carroll, Wilbert Zwart, et al.
BMJ (Clinical Research Ed.)|January 1, 2009
Adjuvant radiotherapy for breast cancerCrispin Hiley, Andrew Tutt, Mylin Torres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Does ER-betacx really have no clinical importance in tamoxifen-treated breast cancer patients?Carlo Palmieri, Ondrej Gojis, Bharath Rudraraju, et al.
The Breast Journal|August 4, 2009
Fulvestrant in advanced breast cancer following tamoxifen and aromatase inhibition: a single center experienceJayson Wang, Sandeep Jain, Charles R Coombes, et al.
Pageof 14